Medis Product Portfolio

Filters

Therapeutic Area

Toggle

Dosage Form

Toggle

Showing 10 of 13 results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Dabrafenib

Status:
Under Development
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
50mg, 75mg
Dosage Form:
Capsule, Hard
Availability:
Under Development

Fingolimod

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
0.25mg, 0.5mg
Dosage Form:
Capsule, Hard
Availability:
Available

Fluconazole

Status:
Available
Therapeutic Area:
Antiinfectives for Systemic Use
Dosage:
50mg, 100mg, 150mg, 200mg
Dosage Form:
Capsule, Hard
Availability:
Available

Fluoxetine

Status:
Under Development, with specific restrictions
Therapeutic Area:
Nervous System
Dosage:
20mg
Dosage Form:
Capsule, Hard
Availability:
Under Development, with specific restrictions

Gabapentin

Status:
Available
Therapeutic Area:
Nervous System
Dosage:
100mg, 300mg, 400mg
Dosage Form:
Capsule, Hard
Availability:
Available

Lenalidomide

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg
Dosage Form:
Capsule, Hard
Availability:
Available

Lenvatinib

Status:
Under Development
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
4mg, 10mg
Dosage Form:
Capsule, Hard
Availability:
Under Development

Lisdexamfetamine

Status:
Available
Therapeutic Area:
Nervous System
Dosage:
20mg, 30mg, 40mg, 50mg, 60mg, 70mg
Dosage Form:
Capsule, Hard
Availability:
Available

Oseltamivir

Status:
Available, with specific restrictions
Therapeutic Area:
Antiinfectives for Systemic Use
Dosage:
30mg, 45mg, 75mg
Dosage Form:
Capsule, Hard
Availability:
Available, with specific restrictions

Pomalidomide

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
1mg, 2mg, 3mg, 4mg
Dosage Form:
Capsule, Hard
Availability:
Available

IP Disclaimer: Not all the products are available for all territories. Please check availability with Medis business development.